Soleus Capital Management, L.P.

Position in WGS — GeneDx Holdings Corp.

CIK 1802630 GREENWICH, CT

Position in WGS

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$686,500

-$3,005,900 QoQ

Shares Held

10,000

-75.0% QoQ

Ownership

0.034%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#112

of 222 holders

Holding Since

Mar 2023

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Soleus Capital Management, L.P. holds $26,549,683 across 6 Diagnostics & Research names. WGS ranks #4 (2.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BDSX	Biodesix Inc	585,958	$13,213,352
2	TWST	Twist Bioscience Corp	104,629	$10,764,231
3	VCYT	Veracyte, Inc.	25,000	$1,468,250
4	WGS	GeneDx Holdings Corp. This page	10,000	$686,500
5	NTRA	Natera, Inc.	1,000	$271,450
6	NEO	Neogenomics Inc	10,000	$145,900

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$686,500	10,000	-75.0%	Shares	Sole	2026-08-11
2025-06-30	$3,692,400	40,000	+900.0%	Shares	Sole	2025-08-15
2024-12-31	$307,440	4,000	-95.4%	Shares	Sole	2025-02-14
2024-06-30	$2,274,180	87,000	-88.9%	Shares	Sole	2024-08-14
2024-03-31	$7,152,222	783,376	+1205.6%	Shares	Sole	2024-05-15
2023-12-31	$165,000	60,000	-92.3%	Shares	Sole	2024-02-14
2023-09-30	$2,844,281	781,396	+9.8%	Shares	Sole	2023-11-14
2023-06-30	$4,239,920	711,396	-96.0%	Shares	Sole	2023-08-14
2023-03-31	$6,548,099	17,940,000	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.